RGC Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Regencell Bioscience Holdings Securities Lawsuit - Contact Levi & Korsinsky

Notice to Pension Funds, Asset Managers, and Fiduciaries Holding RGC: A $14 Billion Market Valuation Built on Zero Revenue and Twelve Employees Now Faces a DOJ Investigation, Creating Potential Fiduciary Exposure NEW YORK, June 17, 2026 /PRNewswire/ -- Institutional investors holding...